⌘+K

Pulse Explore Communities Researchers Journals

Browser extensionInstagram

Home Communities Explore

May 15, 2024Open Access

Supplementary Figure S1 from Response Rate and Molecular Correlates to Encorafenib and Binimetinib in BRAF-V600E Mutant High-Grade Glioma

Karisa C. Schreck Roy E. Strowd Burt Nabors Benjamin M. Ellingson Michael Chang Sze Kiat Tan Zied Abdullaev Rust Turakulov Kenneth Aldape Neeraja Danda Serena Desideri Joy Fisher Michaella Iacoboni Trisha Surakus Michelle A. Rudek Chetan Bettegowda Stuart A. Grossman Xiaobu Ye

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Supplementary Figure S1: Study schema.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Schreck et al. (2024) studied this question.

synapsesocial.com/papers/68e6a13db6db643587624dd0 https://doi.org/10.1158/1078-0432.25826600

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure S1 from Response Rate and Molecular Correlates to Encorafenib and Binimetinib in BRAF-V600E Mutant High-Grade Glioma2024
2Supplementary Figure S3 from Response Rate and Molecular Correlates to Encorafenib and Binimetinib in BRAF-V600E Mutant High-Grade Glioma2024
3Supplementary Figure S3 from Response Rate and Molecular Correlates to Encorafenib and Binimetinib in BRAF-V600E Mutant High-Grade Glioma2024
4Supplementary Material 1 from Response Rate and Molecular Correlates to Encorafenib and Binimetinib in BRAF-V600E Mutant High-Grade Glioma2024
5Supplementary Material 1 from Response Rate and Molecular Correlates to Encorafenib and Binimetinib in BRAF-V600E Mutant High-Grade Glioma2024
6Data from Response Rate and Molecular Correlates to Encorafenib and Binimetinib in BRAF-V600E Mutant High-Grade Glioma2024 · 1 citations
7Supplementary Figure 1 from Antitumor efficacy of dual blockade with encorafenib plus cetuximab in combination with chemotherapy in human <i>BRAFV600E</i> mutant colorectal cancer.2024
8Supplementary Figure 1 from Antitumor efficacy of dual blockade with encorafenib plus cetuximab in combination with chemotherapy in human <i>BRAFV600E</i> mutant colorectal cancer.2024